[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100604259":3},{"organization":4,"armGroups":7,"interventions":20,"overallOfficials":34,"centralContacts":39,"locations":45,"responsibleParty":85,"collaborators":25,"id":87,"slug":25,"hasResults":88,"nctId":89,"briefTitle":90,"officialTitle":90,"acronym":25,"eligibilityCriteria":91,"healthyVolunteers":88,"sex":92,"minAge":93,"maxAge":25,"enrollmentInfo":94,"targetDuration":25,"studyType":97,"phases":98,"briefSummary":100,"conditions":101,"keywords":103,"overallStatus":48,"whyStopped":25,"lastUpdateSubmitDate":105,"lastUpdatePostDateStruct":106,"startDateStruct":109,"completionDateStruct":111,"leadSponsor":113,"locationsCount":114},{"fullName":5,"class":6},"Alcon Research","INDUSTRY",[8,15],{"label":9,"type":10,"description":11,"interventionNames":12},"AAL-FAIOL","EXPERIMENTAL","The clouded lens will be removed by phacoemulsification, after which the AAL-FAIOL will be implanted in one eye.",[13,14],"Device: AAL-FAIOL","Procedure: Phacoemulsification",{"label":16,"type":10,"description":17,"interventionNames":18},"BAL-FAIOL","The clouded lens will be removed by phacoemulsification, after which the BAL-FAIOL will be implanted in one eye.",[19,14],"Device: BAL-FAIOL",[21,26,29],{"type":22,"name":9,"description":23,"armGroupLabels":24,"otherNames":25},"DEVICE","Intraocular lens (IOL) placed into the lens capsule of the eye during cataract surgery. IOLs are implantable medical devices intended for long-term use over the lifetime of the pseudophakic subject. Laser energy to specified locations can be used to allow a change in power for far distances.",[9],null,{"type":22,"name":16,"description":27,"armGroupLabels":28,"otherNames":25},"Intraocular lens (IOL) placed into the lens capsule of the eye during cataract surgery. IOLs are implantable medical devices intended for long-term use over the lifetime of the pseudophakic subject.",[16],{"type":30,"name":31,"description":32,"armGroupLabels":33,"otherNames":25},"PROCEDURE","Phacoemulsification","Cataract surgery technique that uses ultrasound to break up and remove the clouded lens, allowing for intraocular lens (IOL) implantation.",[9,16],[35],{"name":36,"affiliation":37,"role":38},"Clinical Trial Lead, Surgical","Alcon Research, LLC","STUDY_DIRECTOR",[40],{"name":41,"role":42,"phone":43,"phoneExt":25,"email":44},"Alcon Call Center","CONTACT","1-888-451-3937","alcon.medinfo@alcon.com",[46,57,67,76],{"facility":47,"status":48,"city":49,"state":25,"zip":25,"country":50,"cosmosGeoPoint":51,"geoPoint":56,"contacts":25},"Clinica 20\u002F20","RECRUITING","San José","Costa Rica",{"type":52,"coordinates":53},"Point",[54,55],-84.08489,9.93388,{"lat":55,"lon":54},{"facility":58,"status":59,"city":60,"state":25,"zip":25,"country":61,"cosmosGeoPoint":62,"geoPoint":66,"contacts":25},"Instituto Espaillat Cabral","NOT_YET_RECRUITING","Santo Domingo","Dominican Republic",{"type":52,"coordinates":63},[64,65],-69.89232,18.47186,{"lat":65,"lon":64},{"facility":68,"status":59,"city":69,"state":25,"zip":25,"country":70,"cosmosGeoPoint":71,"geoPoint":75,"contacts":25},"Centro Panamericano de Ojos \u002F Clinica Lopez Beltran","San Salvador","El Salvador",{"type":52,"coordinates":72},[73,74],-89.18718,13.68935,{"lat":74,"lon":73},{"facility":77,"status":48,"city":78,"state":25,"zip":25,"country":79,"cosmosGeoPoint":80,"geoPoint":84,"contacts":25},"Panama Eye Center","Panama City","Panama",{"type":52,"coordinates":81},[82,83],-79.51973,8.9936,{"lat":83,"lon":82},{"type":86,"investigatorFullName":25,"investigatorTitle":25,"investigatorAffiliation":25,"oldNameTitle":25,"oldOrganization":25},"SPONSOR","100604259",false,"NCT07147192","Feasibility Study of an Accommodating IOL Design","Key Inclusion Criteria:\n\n* Able to understand and sign an Informed Consent Form.\n* Willing and able to attend all scheduled study visits required per protocol.\n* Diagnosed with bilateral cataracts requiring removal by phacoemulsification.\n* Preoperative corneal astigmatism equal to or less than 1.50 diopter (D) in both eyes.\n* Other protocol-defined inclusion criteria may apply.\n\nKey Exclusion Criteria:\n\n* Women of childbearing potential who are pregnant, intend to become pregnant during the study, or are breastfeeding.\n* Taking medications that could increase risk or may affect accommodation.\n* Eye conditions as specified in the protocol, including glaucoma or ocular hypertension.\n* Medical conditions that could increase operative risk as specified in the protocol.\n* Other protocol-defined exclusion criteria may apply.","ALL","22 Years",{"count":95,"type":96},85,"ESTIMATED","INTERVENTIONAL",[99],"NA","The purpose of this clinical study is to assess safety and explore usability and effectiveness of the test product, AAL-FAIOL. This study will be conducted in Central America.",[102],"Aphakia",[104],"Cataract","2026-05-18",{"date":107,"type":108},"2026-05-19","ACTUAL",{"date":110,"type":108},"2025-12-03",{"date":112,"type":96},"2028-01",{"name":5,"class":6},4]